These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11984384)

  • 41. Methodological considerations with secondary analyses.
    Pollack CD
    Outcomes Manag Nurs Pract; 1999; 3(4):147-52. PubMed ID: 10876539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing the quality of randomized controlled trials. Current issues and future directions.
    Moher D; Jadad AR; Tugwell P
    Int J Technol Assess Health Care; 1996; 12(2):195-208. PubMed ID: 8707495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Four "lessons learned" while implementing a multi-site caries prevention trial.
    Bader JD; Robinson DS; Gilbert GH; Ritter AV; Makhija SK; Funkhouser KA; Amaechi BT; Shugars DA; Laws R;
    J Public Health Dent; 2010; 70(3):171-5. PubMed ID: 20459464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Facilitating research within clinical settings: the development of a beginner's guide.
    Cleary M; Freeman A
    Int J Ment Health Nurs; 2005 Sep; 14(3):202-8. PubMed ID: 16181158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reliability and validity in research.
    Roberts P; Priest H
    Nurs Stand; 2006 Jul 12-18; 20(44):41-5. PubMed ID: 16872117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The questionable use of unequal allocation in confirmatory trials.
    Hey SP; Kimmelman J
    Neurology; 2014 Jan; 82(1):77-9. PubMed ID: 24306005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.
    Godwin M; Ruhland L; Casson I; MacDonald S; Delva D; Birtwhistle R; Lam M; Seguin R
    BMC Med Res Methodol; 2003 Dec; 3():28. PubMed ID: 14690550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Data and safety monitoring in social behavioral intervention trials: the REACH II experience.
    Czaja SJ; Schulz R; Belle SH; Burgio LD; Armstrong N; Gitlin LN; Coon DW; Martindale-Adams J; Klinger J; Stahl SM
    Clin Trials; 2006; 3(2):107-18. PubMed ID: 16773953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies.
    Chan S; Bhandari M
    J Bone Joint Surg Am; 2007 Sep; 89(9):1970-8. PubMed ID: 17768194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Important issues in planning and conducting multi-centre randomised trials in cancer and publishing their results.
    Girling DJ
    Crit Rev Oncol Hematol; 2000 Oct; 36(1):13-25. PubMed ID: 10996520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methodologic Quality and Statistical Reporting of Physical Therapy Randomized Controlled Trials Relevant to Musculoskeletal Conditions.
    Gonzalez GZ; Moseley AM; Maher CG; Nascimento DP; Costa LDCM; Costa LO
    Arch Phys Med Rehabil; 2018 Jan; 99(1):129-136. PubMed ID: 28962828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management and conduct of randomized controlled trials.
    Knatterud GL
    Epidemiol Rev; 2002; 24(1):12-25. PubMed ID: 12119852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. n-of-1 randomized controlled trials: an opportunity for complementary and alternative medicine evaluation.
    Johnston BC; Mills E
    J Altern Complement Med; 2004 Dec; 10(6):979-84. PubMed ID: 15673992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of preventive studies of Chinese Journal of Tuberculosis and Respiratory Diseases 1978-1997].
    Dong B; Zhang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jun; 22(6):329-31. PubMed ID: 11775818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The citation of relevant systematic reviews and randomised trials in published reports of trial protocols.
    Pandis N; Fleming PS; Koletsi D; Hopewell S
    Trials; 2016 Dec; 17(1):581. PubMed ID: 27927219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Redefining the randomized controlled trial in the context of acupuncture research.
    Walji R; Boon H
    Complement Ther Clin Pract; 2006 May; 12(2):91-6. PubMed ID: 16648085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancing the validity and utility of randomized clinical trials in addictions treatment research: III. Data processing and statistical analysis.
    Del Boca FK; Darkes J
    Addiction; 2007 Sep; 102(9):1356-64. PubMed ID: 17511751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [How (in-)complete are study reports?].
    Rakowitz B
    Dtsch Med Wochenschr; 2011 Apr; 136(15):752. PubMed ID: 21488003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.